Friedberg Ezra M 4

What Happened

• Ezra M. Friedberg, a director of Pelthos Therapeutics (PTHS), disposed of 144 shares on May 14, 2026 to satisfy estimated tax obligations tied to the vesting of restricted stock units. The weighted-average sale price was $27.01 per share, for total proceeds of approximately $3,889. This was a sale (tax-withholding) rather than an open-market purchase.

Key Details

• Transaction date: 2026-05-14; Form 4 filed: 2026-05-18 (filed late — transactionTimeliness = L).
• Price: weighted average $27.01; executed in multiple trades at $27.00 to $27.0101.
• Shares reported disposed: 144; aggregate value ≈ $3,889.
• Shares owned after transaction: not disclosed in the provided filing.
• Notable footnotes:
  • Sale made pursuant to a Rule 10b5-1 plan adopted Dec 16, 2025 to satisfy tax obligations from RSU vesting (Footnote F1).
  • Reporting person will provide detailed trade-by-trade info on request (Footnote F2).
  • Mr. Friedberg is manager of Balmoral Financial Group LLC and Key Recovery Group LLC and may be deemed to beneficially own shares held by those entities, though he disclaims such ownership except to the extent of any pecuniary interest (Footnote F3).

Context

• Transaction code F indicates shares were used for tax withholding related to vesting (common administrative transaction), not a directional investment bet. The sale was executed under a prearranged 10b5-1 plan, which reduces timing-question concerns. The late filing (4 days after the trade) is noted by the filer and may be an administrative tardiness rather than substantive trading activity.